IN

Ittilavalappil Naryanan Rajesh

Active Director Whole-Time Director DIN 06361376
DIN 06361376 First appointment Aug 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Aug 2012
Shareholding value •••• Premium profile

About Ittilavalappil Naryanan Rajesh

Data last updated:

Ittilavalappil Naryanan Rajesh is a Whole-Time Director at Aswini Hospital Limited (since 2020), Director at Aswini Health Care Ltd (since 2012) and Director at Puzhakkal Farmer Producer Company Limited (since 2021). The companies operate in Healthcare, Financial Services and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹56.69 Cr; the largest is Aswini Hospital Limited at ₹54.91 Cr (FY 2025). Earlier, Ittilavalappil Naryanan Rajesh was a Director at Punarjani Securities Limited (2012–2015) and Director at Dr Line Labs And Diagnostic Private Limited (from 2022).

DIN 06361376
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 14 Aug 2012
Oldest Company Age 46 yrs
Largest company Aswini Hospital Limited · ₹54.91 Cr (FY 2025)
Combined revenue ₹56.69 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aswini Hospital Limited U85110KL1980PLC003160
Whole-Time Director09 Jan 20201980₹54.91 Cr (FY 2025)Active
Aswini Health Care Ltd U85199KL1994PLC007948
Director12 Sep 20121994₹1.79 Cr (FY 2023)Active
Director14 Oct 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Punarjani Securities Limited U67120KL2012PLC030684
Director14 Aug 20122012₹54.02 Cr (FY 2018)Active
Director06 Jul 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Puzhakkal Farmer Producer Company Limited
Aswini Health Care Ltd
Dr Line Labs And Diagnostic Private Limited
Aswini Hospital Limited
Premium access

Shareholding and investment profile for Ittilavalappil Naryanan Rajesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ittilavalappil Naryanan Rajesh

Ittilavalappil Naryanan Rajesh currently holds 3 directorships: Aswini Hospital Limited (Whole-Time Director, since 09 Jan 2020, revenue ₹54.91 Cr (FY 2025)); Aswini Health Care Ltd (Director, since 12 Sep 2012, revenue ₹1.79 Cr (FY 2023)); Puzhakkal Farmer Producer Company Limited (Director, since 14 Oct 2021).

Ittilavalappil Naryanan Rajesh was first appointed on 14 Aug 2012 as Director at Punarjani Securities Limited. The most recent appointment on record is 06 Jul 2022 at Dr Line Labs And Diagnostic Private Limited.

The 2 current companies of Ittilavalappil Naryanan Rajesh that report revenue have a combined latest revenue of ₹56.69 Cr: Aswini Hospital Limited ₹54.91 Cr (FY 2025); Aswini Health Care Ltd ₹1.79 Cr (FY 2023).

Ittilavalappil Naryanan Rajesh held 2 earlier board appointments: Punarjani Securities Limited (Director, 14 Aug 2012 to 15 Jun 2015); Dr Line Labs And Diagnostic Private Limited (Director, from 06 Jul 2022).

The current boards of Ittilavalappil Naryanan Rajesh's companies include Alungal Chozhikkutty Premanandan (Aswini Hospital Limited), Alungal Chozhikutty Velayudhan (Aswini Hospital Limited), Aruketty Sankaranarayanan Dharman (Aswini Hospital Limited), Meleppura Unniri Unnikrishnan (Aswini Hospital Limited), Ozhukil Padinjarepet Achuthan Kutty (Aswini Hospital Limited), Pradeep Chembil Chandran (Aswini Hospital Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available